Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty. Scope of the Report: This report focuses on the Drugs for Schistosomiasis in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application. Market Segment by Manufacturers, this report covers Shin Poong Merck Bayer EIPICO Chandra Bhagat Pharma Taj Pharmaceuticals Market Segment by Countries, covering China Japan Korea Taiwan Southeast Asia India Australia Market Segment by Type, covers Praziquantel Oxamniquine Other Market Segment by Applications, can be divided into S. haematobium S. mansoni S. japonicum S. mekongi S. intercalatum There are 19 Chapters to deeply display the Asia-Pacific Drugs for Schistosomiasis market. Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Drugs for Schistosomiasis, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application; Chapter 14, Drugs for Schistosomiasis market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 17, to describe sales channel, distributors, traders, dealers etc. Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Drugs for Schistosomiasis Introduction 1.2 Market Analysis by Type 1.2.1 Praziquantel 1.2.2 Oxamniquine 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 S. haematobium 1.3.2 S. mansoni 1.3.3 S. japonicum 1.3.4 S. mekongi 1.3.5 S. intercalatum 1.4 Market Analysis
